The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
